A$3.06 pre-market: Artrya (AYA.AX) ASX 19 Mar 2026 AI stock outlook
AYA.AX stock opened pre-market at A$3.06 on 19 Mar 2026 as investors assess Artrya Limited’s AI diagnostic traction in coronary disease. Artrya (AYA.AX) trades on the ASX and has a market capitalisation of A$350,504,000 while trading between A$3.04 and A$3.15 intraday. The company’s cloud AI product Salix targets automated coronary CT angiography reads, and recent trading reflects mixed sentiment between robust cash per share and negative earnings. We examine fundamentals, technicals, Meyka AI grades and model forecasts to outline near-term scenarios for this AI healthcare stock.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
